Liminal BioSciences Inc. (LMNL)
NASDAQ: LMNL
· Real-Time Price · USD
8.50
0.01 (0.12%)
At close: Sep 25, 2023, 9:59 PM
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
| Canada Revenue | 3K | 78K | 672K | 1.88M |
| Canada Revenue Growth | -96.15% | -88.39% | -64.27% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jul 19, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.78M | 3.56M | 3.94M | 4.39M | 4.65M | 4.89M | 5.82M | 9.42M | 8.55M | 9.14M | 9.07M | 8.96M | 9.85M | 10.67M | 8.73M | 10.32M | 18.59M | 7.64M | 10.66M | 6.22M | 6.94M | 7.7M | 8.78M | 7.65M | 8.06M | 6.95M | 12.82M | 6.47M | 5.18M | 4.83M | 5.33M | 4.13M | 3.77M | 3.21M |
| Selling, General, and Administrative Revenue Growth | +34.19% | -9.65% | -10.19% | -5.62% | -5.05% | -15.91% | -38.22% | +10.16% | -6.43% | +0.76% | +1.24% | -9.05% | -7.69% | +22.25% | -15.40% | -44.49% | +143.20% | -28.31% | +71.38% | -10.40% | -9.85% | -12.28% | +14.74% | -5.06% | +16.05% | -45.80% | +97.93% | +24.90% | +7.42% | -9.46% | +29.09% | +9.55% | +17.41% | n/a |
| Research and Development Revenue | 4.34M | 4.17M | 3.46M | 3.52M | 3.94M | 4.38M | 4.54M | 4.97M | 3.95M | 9.25M | 11.64M | 12.41M | 15.8M | 16.98M | 12.16M | 19.61M | 24.16M | 19.19M | 21.14M | 24.11M | 24M | 22.42M | 28.42M | 23.2M | 24.45M | 24.31M | 28.67M | 23.58M | 19.35M | 16.48M | 17.93M | 11.9M | 10.67M | 9.88M |
| Research and Development Revenue Growth | +4.08% | +20.42% | -1.62% | -10.73% | -9.90% | -3.61% | -8.73% | +25.87% | -57.29% | -20.51% | -6.22% | -21.45% | -6.99% | +39.68% | -37.98% | -18.84% | +25.87% | -9.22% | -12.30% | +0.42% | +7.08% | -21.14% | +22.51% | -5.12% | +0.58% | -15.20% | +21.62% | +21.83% | +17.44% | -8.11% | +50.72% | +11.51% | +7.96% | n/a |